As the high frequency of TP53 mutation in ESCC, and evidence from recent studies showed that p53 missense mutations abrogate its tumor‐suppressive function and lead to a “gain‐of‐function” that promotes cancer, it might be worthwhile to try those approaches in the treatment of this deadly cancer 6, 32, 33. This evidence concerns the gene TP53 and cancer.